Vincamine

Vincamine

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C04AX07 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name (3α,14β,16α)-14,15-dihydro- 14-hydroxyeburnamenine-14-carboxylic acid methyl ester OR methyl (15R,17S,19R)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate
CAS Number	1617-90-9 Y
PubChem Template:Abbreviation	15376
IUPHAR/BPS	349
ChemSpider	14635 N
UNII	996XVD0JHT
KEGG	D08677 Y
ChEMBL	ChEMBL1165342 N
Chemical and physical data
Formula	C21H26N2O3
Molar mass	354.44 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(OC)[C@]3(O)n1c4c(c2ccccc12)CCN5CCC[C@](C3)(CC)[C@@H]45
InChI InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1 N Key:RXPRRQLKFXBCSJ-GIVPXCGWSA-N N
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Vincamine
Articles
Most recent articles on Vincamine Most cited articles on Vincamine Review articles on Vincamine Articles on Vincamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Vincamine Images of Vincamine Photos of Vincamine Podcasts & MP3s on Vincamine Videos on Vincamine
Evidence Based Medicine
Cochrane Collaboration on Vincamine Bandolier on Vincamine TRIP on Vincamine
Clinical Trials
Ongoing Trials on Vincamine at Clinical Trials.gov Trial results on Vincamine Clinical Trials on Vincamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Vincamine NICE Guidance on Vincamine NHS PRODIGY Guidance FDA on Vincamine CDC on Vincamine
Books
Books on Vincamine
News
Vincamine in the news Be alerted to news on Vincamine News trends on Vincamine
Commentary
Blogs on Vincamine
Definitions
Definitions of Vincamine
Patient Resources / Community
Patient resources on Vincamine Discussion groups on Vincamine Patient Handouts on Vincamine Directions to Hospitals Treating Vincamine Risk calculators and risk factors for Vincamine
Healthcare Provider Resources
Symptoms of Vincamine Causes & Risk Factors for Vincamine Diagnostic studies for Vincamine Treatment of Vincamine
Continuing Medical Education (CME)
CME Programs on Vincamine
International
Vincamine en Espanol Vincamine en Francais
Business
Vincamine in the Marketplace Patents on Vincamine
Experimental / Informatics
List of terms related to Vincamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vincamine is a peripheral vasodilator that increases blood flow to the brain (sold under the trademark Oxybral SR) . Generic drugs containing vincamine exist in specific regions. Most common drug preparations are in the sustained release forms. Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor, comprising about 25-65% of the indole alkaloids found in Vinca minor by weight. It can be synthesized from related alkaloids.

Vincamine is often used as a nootropic agent to combat the effects of aging, or in conjunction with other nootropics (such as piracetam) for a variety of purposes.

External Links

• "Vincamine MSDS" (pdf).
• Chemical Selection Working Group. "Vincamine - 1617-90-9" (pdf). Summary of Data for Chemical Selection. NIH - United States National Institutes of Health.

See also

• Vinpocetine